KYTHERA BIOPHARMACEUTICALS, INC.
Proposal 1
APPROVAL OF THE AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER, DATED AS OF AUGUST 4, 2015 (AS IT MAY BE FURTHER AMENDED FROM TIME TO TIME), BY AND AMONG ALLERGAN PLC, KETO MERGER SUB, INC. AND KYTHERA BIOPHARMACEUTICALS, INC. (THE "MERGER PROPOSAL")
Caisse vote:
For
Applicable policy or principle:
PR_03
Proposal 2
APPROVAL OF THE ADJOURNMENT OF THE SPECIAL MEETING TO ANOTHER DATE AND PLACE IF NECESSARY OR APPROPRIATE TO SOLICIT ADDITIONAL VOTES IN FAVOR OF THE MERGER PROPOSAL
Caisse vote:
Against
Applicable policy or principle:
PR_14
Proposal 3
APPROVAL, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION TO BE PAID TO KYTHERA BIOPHARMACEUTICALS, INC.'S NAMED EXECUTIVE OFFICERS THAT IS BASED ON OR OTHERWISE RELATES TO THE MERGER
Caisse vote:
For
Applicable policy or principle:
PR_07_08